ReviewTrabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice☆
Introduction
Measurements of bone mineral density (BMD) are a central component of any provision that arises from the definition of osteoporosis, agreed internationally as: a progressive systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to fracture [1]. This definition captures the notion that low areal BMD (aBMD) is an important component of fracture risk, but that other bone abnormalities contribute to skeletal fragility. The conceptual description of osteoporosis thus centres both on the assessment of bone mass and quality, specifically bone microstructure. Until recently, there were no satisfactory clinical means to assess bone microstructure non-invasively, so that the operational diagnosis of osteoporosis is based on the measurement of aBMD. Osteoporosis is so-defined as a femoral neck aBMD 2.5 SD or more below the young adult female mean (T-score ≤ − 2.5) [2], [3]. The same T-score derived at other sites is widely used in clinical practice (e.g., lumbar spine, total hip, distal radius).
A consequence of this operational definition, which identifies the small proportion of the population at highest risk, is that the greater number of individuals above this threshold, although individually at lower risk, contributes the greater number of fractures to the total burden. Indeed, the majority of fragility fractures occur in patients who have an aBMD T-score > − 2.5. In other words, the detection rate for these fractures (sensitivity) is low [4], which is why widespread population-based screening is not generally recommended in women at menopause [2], [5]. Thus, factors other than bone mass influence bone strength and fracture risk, including microarchitectural deterioration of bone tissue, as given in the conceptual definition of osteoporosis. Additional skeletal and extra-skeletal factors, such as bone geometry, micro-damage, mineralization, bone turnover, age, and a large range of clinical risk factors, including family history, prior fracture and fall risk, contribute to the overall assessment of fracture risk [6], [7], [8], [9]. Several of these additional factors are captured by FRAX®. FRAX estimates the 10-year probability of hip and major osteoporotic fracture based on the individual's risk factor profile [4]. Apart from BMD, FRAX does not capture other skeletal determinants of bone strength that improve upon or are at least partly independent of aBMD [10]. Several such determinants are the subject of clinical research [11], [12], [13], [14], [15], [16], [17], [18] using novel imaging techniques, such as quantitative computed tomography (QCT) and high resolution (peripheral) QCT [19], [20], and minimally invasive approaches for probing bone material properties, notably microindentation techniques [21]. Although there is evidence of their predictive ability for fracture [22], [23], none of these modalities appears to reliably outperform aBMD in the prediction of the various types of osteoporotic fractures, and their general lack of availability and validation in the clinical setting means that an adjunctive role alongside DXA-measured aBMD is unlikely to be feasible in most settings in the near future. In contrast, trabecular bone score (TBS) is a novel imaging technique, based on standard DXA images, and appears to constitute an index of bone texture that provides skeletal information additional to the standard aBMD results [24].
TBS has emerged as a novel grey-level texture measurement that uses experimental variograms of 2D projection images, quantifying variation in grey-level texture from 1 pixel to the adjacent pixels. TBS is not a direct measurement of bone microarchitecture but it is related to 3D bone characteristics such as the trabecular number, the trabecular separation and the connectivity density [25], [26]. An elevated TBS appears to represent strong, fracture-resistant microarchitecture, whilst a low TBS reflects weak, fracture-prone microarchitecture. As such, there is evidence that TBS can differentiate between two 3-dimensional (3D) microarchitectures that exhibit the same bone density, but different trabecular characteristics. TBS is generally obtained by re-analysis of AP lumbar spine DXA images, which allows direct comparison with aBMD and application to existing datasets. This latter opportunity has led to a rapid rise in published research assessing its potential role in the assessment and management of osteoporosis.
Lumbar TBS, like aBMD, is an age dependent variable. Little change in TBS is observed between the ages of 30 and 45 years. Thereafter, a progressive decrease is observed with advancing age [27], which is more marked in women than in men. The percentage decrease with age is similar to that for lumbar spine aBMD, as is the short term reproducibility [25].
This paper reports the findings of a European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) Working Group, which first convened in September 2014 with the aim of comprehensively assessing the evidence supporting the use of TBS in clinical practice. More specifically, this report reviews the potential value of TBS as an independent adjunct to risk assessment using DXA aBMD and/or FRAX in settings such as post-menopausal and secondary osteoporosis, and its potential use in assessment of response to treatment.
A Medline search for publications with the terms trabecular bone score or TBS was undertaken in September 2014. Published articles in English and French were extracted. Papers in abstract form were not included except where the authors supplied a full copy of the submitted manuscript. A total of 479 papers were identified of which 67 manuscripts were considered relevant and the full publication reviewed. The search was subsequently updated in February 2015 and a total of 73 papers were reviewed.
Section snippets
Does TBS predict osteoporosis-related fracture risk?
To date, eighteen studies assessing fracture risk in post-menopausal women have been published. Of these, eleven were cross-sectional [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38] and seven prospective, including a meta-analysis [25], [39], [40], [41], [42], [43], [44].
Is TBS a potential adjunct to FRAX® probability?
FRAX is widely used as a fracture risk assessment tool and the question arises whether TBS might serve as an adjunct to FRAX risk factors in the stratification of fracture risk. For TBS to be considered clinically useful as a FRAX modifier, it should be at least partly independent of lumbar spine aBMD, femoral neck aBMD and FRAX clinical risk factors (CRFs). An assessment of the relationship between CRFs, aBMD and TBS was undertaken in the Manitoba cohort, in which 33,352 women aged 40–100 years
Is TBS responsive to treatment?
Several relatively small studies have examined treatment-induced changes in TBS [49], [50], [53], [56], [57], [58], [59] (Table 3). Of these, four were studies of osteoporosis treatment in postmenopausal women, one in both men and women with osteoporosis, and two in the management of breast cancer. One of these compared a specific oestrogen-receptor modifier (tamoxifen) and an aromatase inhibitor (exemestane) in breast cancer patients.
In Manitoba, 534 post-menopausal women treated with a
Does TBS have a role in secondary osteoporosis?
Although in many cases, osteoporosis is idiopathic, there are a number of specific causes of bone fragility that result in “secondary osteoporosis”. Evidence is emerging that TBS might provide useful information with regards to bone health in several clinical contexts [68].
Conclusions
In recent years, there has been increasing interest in the use of TBS, a surrogate of bone microarchitecture, for risk stratification in osteoporosis. The present assessment of the existing literature indicates that low lumbar spine TBS is associated with both a history of fracture and the incidence of new fracture. The effect is independent of aBMD and of sufficient magnitude to enhance risk stratification with aBMD. The effect is also partly independent of FRAX with likely greatest utility
Disclosures
NH has received consultancy, lecture fees and honoraria from the Alliance for Better Bone Health, AMGEN, MSD, Eli Lilly, Servier, Shire, Consilient Healthcare, Internis Pharma and Firefly Pharma.
CCG is a member of the Medimaps advisory board and has received consultancy fees from Medimaps.
RR has received speaker or advisory board fees from Amgen, MSD, GSK, Servier, Danone and Takeda.
NB has received research support from Amgen, Lilly, Merck, Opko Ireland, and GE Healthcare Lunar. He also
Acknowledgments
We are grateful for the assistance of Dr. Kevin P White (medical writer).
References (81)
- et al.
A reference standard for the description of osteoporosis
Bone
(2008) - et al.
Independent predictors of all osteoporosis-related fractures in healthy postmenopausal women: the OFELY study
Bone
(2003) - et al.
A family history of fracture and fracture risk: a meta-analysis
Bone
(2004) - et al.
A meta-analysis of previous fracture and subsequent fracture risk
Bone
(2004) Quantitative ultrasound — it is time to focus research efforts
Bone
(2007)- et al.
High resolution quantitative computed tomography-based assessment of trabecular microstructure and strength estimates by finite-element analysis of the spine, but not DXA, reflects vertebral fracture status in men with glucocorticoid-induced osteoporosis
Bone
(2013) - et al.
Three-dimensional (3D) microarchitecture correlations with 2D projection image gray-level variations assessed by trabecular bone score using high-resolution computed tomographic acquisitions: effects of resolution and noise
J Clin Densitom
(2013) - et al.
Creation of an age-adjusted, dual-energy X-ray absorptiometry-derived trabecular bone score curve for the lumbar spine in non-Hispanic US White women
J Clin Densitom
(2014) - et al.
Spine trabecular bone score subsequent to bone mineral density improves fracture discrimination in women
J Clin Densitom
(2014) - et al.
Vertebral microarchitecture and fragility fracture in men: a TBS study
Bone
(2014)
Evaluation of the potential use of trabecular bone score to complement bone mineral density in the diagnosis of osteoporosis: a preliminary spine BMD-matched, case–control study
J Clin Densitom
Added value of trabecular bone score to bone mineral density for prediction of osteoporotic fractures in postmenopausal women: the OPUS study
Bone
Construction and validation of a population-based bone densitometry database
J Clin Densitom
Clinical risk factors for fracture in postmenopausal Canadian women: a population-based prevalence study
Bone
Correlations between trabecular bone score, measured using anteroposterior dual-energy X-ray absorptiometry acquisition, and 3-dimensional parameters of bone microarchitecture: an experimental study on human cadaver vertebrae
J Clin Densitom
Effects of exemestane and tamoxifen treatment on bone texture analysis assessed by TBS in comparison with bone mineral density assessed by DXA in women with breast cancer
J Clin Densitom
Spine bone texture assessed by trabecular bone score (TBS) predicts osteoporotic fractures in men: the Manitoba Bone Density Program
Bone
Comparison between different bone treatments on areal bone mineral density (aBMD) and bone microarchitectural texture as assessed by the trabecular bone score (TBS)
Bone
2004 Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk
J Clin Densitom
“Trabecular bone score” (TBS): an indirect measure of bone micro-architecture in postmenopausal patients with primary hyperparathyroidism
Bone
Identification of rheumatoid arthritis patients with vertebral fractures using bone mineral density and trabecular bone score
J Clin Densitom
Consensus development conference. Diagnosis, prophylaxis and treatment of osteoporosis
Am J Med
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: technical report series 843
Assessment of osteoporosis at the primary health-care level
Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment
J Bone Miner Res
Age and bone mass as predictors of fracture in a prospective study
J Clin Invest
Prediction of absolute risk of non-spinal fractures using clinical risk factors and heel quantitative ultrasound
Osteoporos Int
Cortical porosity identifies women with osteopenia at increased risk for forearm fractures
J Bone Miner Res
Simple measurement of femoral geometry predicts hip fracture: the study of osteoporotic fractures
J Bone Miner Res
Microindentation for in vivo measurement of bone tissue material properties in atypical femoral fracture patients and controls
J Bone Miner Res
Age-dependence of femoral strength in white women and men
J Bone Miner Res
Applications of a new handheld reference point indentation instrument measuring bone material strength
J Med Devices
Trabecular bone score: a noninvasive analytical method based upon the DXA image
J Bone Miner Res
Use of DXA-based structural engineering models of the proximal femur to discriminate hip fracture
J Bone Miner Res
Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsy
Osteoporos Int
Microindentation for in vivo measurement of bone tissue mechanical properties in humans
J Bone Miner Res
Prediction of new clinical vertebral fractures in elderly men using finite element analysis of CT scans
J Bone Miner Res
Assessment of incident spine and hip fractures in women and men using finite element analysis of CT scans
J Bone Miner Res
Trabecular bone score: a noninvasive analytical method based upon the DXA image
J Bone Miner Res
Bone micro-architecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study
J Bone Miner Res
Cited by (339)
Pathogenesis, assessment, and management of bone loss in axial spondyloarthritis
2024, Seminars in Arthritis and RheumatismFRAX® adjustment using renormalized trabecular bone score (TBS) from L1 alone may be optimal for fracture prediction: The Manitoba BMD registry
2023, Journal of Clinical DensitometryDiffuse idiopathic skeletal hyperostosis (DISH) and trabecular bone score (TBS) in postmenopausal women: The Camargo cohort
2023, Seminars in Arthritis and RheumatismUltrasound attenuation of cortical bone correlates with biomechanical, microstructural, and compositional properties
2024, European Radiology Experimental
- ☆
A consensus report of a European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) Working Group.